DE69615549D1 - Kunsthaut, enthaltend als träger bioverträgliche materialen aus hyaluronsäurederivaten - Google Patents

Kunsthaut, enthaltend als träger bioverträgliche materialen aus hyaluronsäurederivaten

Info

Publication number
DE69615549D1
DE69615549D1 DE69615549T DE69615549T DE69615549D1 DE 69615549 D1 DE69615549 D1 DE 69615549D1 DE 69615549 T DE69615549 T DE 69615549T DE 69615549 T DE69615549 T DE 69615549T DE 69615549 D1 DE69615549 D1 DE 69615549D1
Authority
DE
Germany
Prior art keywords
pct
human skin
bio
carrier
date oct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69615549T
Other languages
English (en)
Other versions
DE69615549T2 (de
Inventor
Carlo Soranzo
Giovanni Abatangelo
Lanfranco Callegaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anika Therapeutics SRL
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of DE69615549D1 publication Critical patent/DE69615549D1/de
Application granted granted Critical
Publication of DE69615549T2 publication Critical patent/DE69615549T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • C12N5/0698—Skin equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/09—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells
    • C12N2502/094—Coculture with; Conditioned medium produced by epidermal cells, skin cells, oral mucosa cells keratinocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/04—Screening or testing on artificial tissues
    • C12N2503/06—Screening or testing on artificial skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69615549T 1995-04-27 1996-04-25 Kunsthaut, enthaltend als träger bioverträgliche materialen aus hyaluronsäurederivaten Expired - Lifetime DE69615549T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95PD000083A IT1281870B1 (it) 1995-04-27 1995-04-27 Pelle artificiale umana costituita da materiali biocompatibili a base di derivati dell'acido ialuronico
PCT/EP1996/001734 WO1996033750A1 (en) 1995-04-27 1996-04-25 Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives

Publications (2)

Publication Number Publication Date
DE69615549D1 true DE69615549D1 (de) 2001-10-31
DE69615549T2 DE69615549T2 (de) 2002-06-06

Family

ID=11391027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69615549T Expired - Lifetime DE69615549T2 (de) 1995-04-27 1996-04-25 Kunsthaut, enthaltend als träger bioverträgliche materialen aus hyaluronsäurederivaten

Country Status (12)

Country Link
US (1) US6110208A (de)
EP (1) EP0822839B1 (de)
JP (1) JP3646882B2 (de)
AT (1) ATE206058T1 (de)
AU (1) AU700762B2 (de)
CA (1) CA2219272A1 (de)
DE (1) DE69615549T2 (de)
DK (1) DK0822839T3 (de)
ES (1) ES2162052T3 (de)
IT (1) IT1281870B1 (de)
PT (1) PT822839E (de)
WO (1) WO1996033750A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528483B2 (en) 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
ES2132027B1 (es) * 1997-07-04 2000-04-01 Comunitario De Transfusion Del Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
AU3220299A (en) 1998-04-02 1999-10-25 Neurogen Corporation Substituted 9h-pyridino(2,3-b)indole and 9h-pyrimidino(4,5-b)indole derivatives:selective neuropeptide y receptor ligands
US6872819B1 (en) 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980149A1 (it) 1998-06-17 1999-12-17 Fidia Advanced Biopolymers Srl Protesi tridimensionali comprendenti derivati dell'acido ialuronico per riparare o ricostruire i tessuti danneggiati e processo per la
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
US6371984B1 (en) * 1999-09-13 2002-04-16 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
US6783546B2 (en) 1999-09-13 2004-08-31 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
JP4074043B2 (ja) * 2000-03-27 2008-04-09 株式会社資生堂 皮膚基底膜形成促進剤、人工皮膚形成促進剤及び人工皮膚の製造方法
DE10041468C1 (de) * 2000-08-23 2002-03-07 Surface Care Gmbh Hautmatrix zur Abdeckung und Regenerierung verletzter Hautpartien sowie Verfahren zu ihrer Herstellung
EP1731132B1 (de) 2000-10-13 2008-12-10 Block Drug Company, Inc. Dentalzusammensetzungen für überempfindliche Zähne
AU2002246747A1 (en) * 2000-12-27 2002-08-06 Ortec International, Inc. Processes for making cryopreserved composite living constructs and products resulting therefrom
WO2002091999A2 (en) * 2001-05-09 2002-11-21 Geron Corporation Treatment for wounds
US8394371B2 (en) 2002-02-11 2013-03-12 Neocutis Sa Compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
WO2004037164A2 (en) 2002-06-21 2004-05-06 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
WO2004028584A1 (en) * 2002-09-30 2004-04-08 Bioland Ltd. Dermal substitute consisting of amnion and biodegradable polymer, the preparation method and the use thereof
US7749728B2 (en) * 2003-06-04 2010-07-06 Cabenda Pharmaceutical Research Limited Method and system for measuring the penetration of drugs and other substances into tissue
US20050271712A1 (en) * 2004-06-04 2005-12-08 Shannon Donald T Multilayer wound covering and therapeutic methods thereof
US20060058238A1 (en) * 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
US8105380B2 (en) * 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
AU2008251467B2 (en) * 2007-05-11 2014-07-31 The Trustees Of The University Of Pennsylvania Methods of treatment of skin ulcers
WO2009045359A1 (en) * 2007-10-01 2009-04-09 Stemnion, Inc. Skin replacement compositions and methods
WO2009154569A1 (en) * 2008-06-20 2009-12-23 The Thailand Research Fund Method and system for producing artificial skin
WO2010132857A1 (en) * 2009-05-14 2010-11-18 Central Michigan University Composition and method of preparation of polysaccharide gel-based artificial, biodegradable skin scaffolds
DE102009022351A1 (de) * 2009-05-15 2010-11-25 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Modulares Produktionssystem zur automatischen Herstellung von dreidimensionalen Gewebestrukturen
FR2950074B1 (fr) 2009-09-16 2017-10-06 Oreal Equivalent de peau in vitro et procede de preparation
WO2013010045A1 (en) 2011-07-12 2013-01-17 Biotime Inc. Novel methods and formulations for orthopedic cell therapy
FR2999083B1 (fr) 2012-12-12 2015-01-23 Univ Nantes Pansement contenant des fibroblastes et des keratinocytes foetaux
EP3900534A1 (de) * 2013-03-13 2021-10-27 Stratatech Corporation Verfahren zum erwärmen kryokonservierter menschlischer hautsubstitute
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
DK3072535T5 (en) * 2015-03-26 2017-06-06 Univ Bordeaux METHOD OF RECONSTRUCTION OF SKIN
CN105169491B (zh) * 2015-10-16 2017-10-24 武汉纺织大学 一种制备真菌高支化多糖‑黄原胶水凝胶支架的方法
CN105944150B (zh) * 2016-03-25 2019-05-10 华东理工大学 一种水凝胶和应用该水凝胶的人工皮肤及其制备方法
PL244125B1 (pl) 2020-05-15 2023-12-04 Politechnika Slaska Im Wincent Kompartmentowy zasobnik do hodowli i namnażania powierzchniowego ludzkich autologicznych fibroblastów na nośniku membranowym

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485096A (en) * 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
ES2111566T3 (es) * 1990-04-24 1998-03-16 Mark Eisenberg Equivalentes compuestos de piel viva.
IT1248934B (it) * 1990-06-01 1995-02-11 Fidia Spa Membrane forate biocompatibili,processi per la loro preparazione,loro impiego come supporto per la crescita in vitro di cellule epiteliali, pelli artificiali cosi' ottenute e loro impiego nei trapianti di pelle
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico

Also Published As

Publication number Publication date
WO1996033750A1 (en) 1996-10-31
AU5647996A (en) 1996-11-18
EP0822839B1 (de) 2001-09-26
EP0822839A1 (de) 1998-02-11
IT1281870B1 (it) 1998-03-03
JPH11503946A (ja) 1999-04-06
AU700762B2 (en) 1999-01-14
DE69615549T2 (de) 2002-06-06
ATE206058T1 (de) 2001-10-15
ITPD950083A0 (it) 1995-04-27
PT822839E (pt) 2002-03-28
ES2162052T3 (es) 2001-12-16
DK0822839T3 (da) 2002-01-21
ITPD950083A1 (it) 1996-10-27
US6110208A (en) 2000-08-29
CA2219272A1 (en) 1996-10-31
JP3646882B2 (ja) 2005-05-11

Similar Documents

Publication Publication Date Title
DE69615549T2 (de) Kunsthaut, enthaltend als träger bioverträgliche materialen aus hyaluronsäurederivaten
Purdue et al. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds
DK0749446T3 (da) Stærkt reaktive estere af carboxypolysaccharider og hidtil ukendte carboxypolysaccharider afledt deraf
CN1198090A (zh) 利用自身真皮成纤维细胞修补皮肤和软组织缺损
DE69231421D1 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
ATE297169T1 (de) Auffindbare künstliche bioimplantate
ATE232748T1 (de) Hemmung von gefässverengungen nach eingriffen an den gefässen
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
DE60313356D1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
PL324424A1 (en) Therapeutic factors and autoimmunological diseases
Fimiani et al. Other uses of homologous skin grafts and skin bank bioproducts
Fabre Epidermal allografts
MacLennan et al. Scalp autografts and hair transfer to the face in the burned child
Barlow et al. The use of a polymeric film for the culture and transfer of sub-confluent autologous keratinocytes to patients
ATE224727T1 (de) Faktor xiii zur behandlung von hautwunden
ATE190507T1 (de) Biodegradierbare führungskanäle zur verwendung als chirurgische hilfsmittel in gewebewiederherstellung
ATE355362T1 (de) Verfahren zur induzierung der osteoblastischen differenzierung der zellen des menschlichen extramedullären fettgewebes
RU2657202C1 (ru) Способ кожной аутопластики
Johnson The role of tissue engineering
ES2142672T3 (es) Dispositivo de canula hipodermica flexible.
Hergrueter et al. Skin substitutes in upper extremity burns
Skolnick Undifferentiated cell transplant techniques appear effective in treating leg ulcers, vitiligo
MD1135F1 (en) Paradontium treatment method
Berthod Tissueengineered skin and the treatment of burns: Skin doctor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FIDIA FARMACEUTICI S.P.A., ABANO TERME, PADUA/PADO

8327 Change in the person/name/address of the patent owner

Owner name: FIDIA ADVANCED BIOPOLYMERS, S.R.L., ABANO TERME, (